Sanofi Breaks Ground on Vaccine Manufacturing Facility

Date Published04/05/2023
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Sanofi
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2023
Domestically, the work will be done:In-house
Country(ies) from which reshored:France
City reshored to:Swiftwater
State(s) reshored to:PA
If relevant, work nearshored to:-
Product(s) reshoredrecombinant pandemic influenza vaccines
What domestic positive factors made reshoring more attractive?Government Incentives, BARDA contract
Find Reshoring Articles